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Background: Limited information is available about Mini Nutritional Assessment (MNA)
questionnaire in patients with chronic obstructive pulmonary disease (COPD). We have
conceived this analysis to study the associations between MNA questionnaire, body
composition, and rehospitalisations in patients with COPD.
Methods: This prospective study recruited control subjects and COPD patients for
pulmonary function testing, nutritional assessment using MNA questionnaire, body
composition measurement, and dyspnoea evaluation. We recorded hospitalisations during
6 months after discharge.
Results: Our sample included 22 healthy controls (71±5 years, 59% men) and 108 COPD
patients (71±10 years, 75% men, 85% severe or very severe COPD). MNA score was
signiﬁcantly higher in control subjects than in COPD patients (27.0±1.7 vs 21.2±4.9,
p < 0.001). MNA score decreased over GOLD stage (p = 0.02) and indicated malnutrition
in 14% of patients, and further 55% were at risk of malnutrition. Body mass index but
not body composition parameters was higher in control subjects when compared to
COPD patients (29.1±3.8 vs 27.0±6.3, p = 0.041). A positive correlation between MNA
score, body fat content (p = 0.001), and lean body mass (p < 0.001) was observed. During
follow-up, 45 (41%) patients were rehospitalised. Malnourished patients had higher risk of
rehospitalisation in univariate analysis (HR 2.62, 95%CI 1.13–6.07), which was maintained
in an adjusted model (HR 2.93, 95%CI 1.05–7.32).
Conclusions: Malnutrition and risk of malnutrition was frequent, associated with lower
body fat mass and lean body mass, and independently predicted hospitalisations at six
months.
© 2011 Elsevier Ltd. All rights reserved.
Introduction
Reverse epidemiology is present in a variety of chronic
disease where traditional risk factors like high body mass
index confer prognostic beneﬁt.1 Indeed, loss of body weight
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is a common and serious problem for patients with chronic
obstructive pulmonary disease (COPD), that can lead to
cachexia.2–4 Nutritional status can be assessed in various
ways but body mass index (BMI), either as a single measure
or part of composite score, remains most used in clinical
practice.5–8 Other measures include determination of body
composition or nutritional assessment but the available
data, particularly about latter, remains scarce.9,10
Mini Nutritional Assessment (MNA) questionnaire is an
established method to identify individuals either at risk of
malnutrition or malnourished subjects.11 In patients with
0954-6111$ – see front matter © 2011 Elsevier Ltd. All rights reserved.
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COPD, risk of malnutrition is present in about half of patients
and is associated with perception of dyspnoea12 and with
deprivileged socioeconomic status.13 Most recent study14
demonstrated that nutritional status as assessed by MNA
questionnaire is independently predicted by COPD severity
and advanced age.
Little data is available about prognostic relevance of
nutritional risk assessment beyond BMI. We have conceived
this analysis to study the associations between MNA
questionnaire, body composition, and rehospitalisations in
patients with COPD.
Methods
Study design and patients
This was a prospective study which recruited patients from
University Clinic of Respiratory and Allergic diseases Golnik.
Study design was detailed elsewhere.15 In brief, consecutive
patients, hospitalised due to acute exacerbation of COPD
between December 2009 and January 2011, were eligible for
the enrolment. Additionally, we required at least moderate
airway obstruction according to Global initiative for chronic
Obstructive Lung Disease (GOLD) guidelines.16 We excluded
patients that were in unstable or terminal stages of disease
other than COPD or if they were unable or unwilling to
undergo study procedures. The control group consisted of
22 healthy volunteers aged >65 years and without history
of chronic diseases, except controlled arterial hypertension.
National Ethics Committee reviewed and approved the study
protocol. Patients were given verbal and written information
about the study and gave written informed consent before
any study related procedure.
Study procedures and measurements
Demographic characteristics, patient history of chronic
disease, and smoking status, were retrieved at patient
interview during hospitalisation or from medical records.
Routine measurements included pulmonary function (forced
expiratory volume in 1st second – FEV1, and vital capac-
ity – VC), body height, body weight, systolic and diastolic
blood pressure and heart rate. Nutritional assessment using
MNA questionnaire, body composition measurement, and
dyspnoea evaluation were performed by same investigator
one day before or on discharge day. Subjects from control
group received same assessment during scheduled visit.
Patients were regularly contacted during follow-up and
returned for a visit at 6 months. Patients and/or relatives
were reminded to attend the visit at phone contact within
one week prior to scheduled visit date.
The Mini Nutritional Assessment (MNA®) questionnaire
The MNA questionnaire is an internationally validated,
two-step procedure that includes screening for risk of
malnutrition and global assessment of the nutritional
conditions.11 Patient total score can range from 0 to
30 points, and patients are classiﬁed as malnourished
(17 points), at risk of malnutrition (17.5–23.5), or well
nourished (>23.5).
Body composition evaluation by bioelectrical impedance
analysis
Bioelectrical impedance analysis (BIA) was performed using
a tetra polar RJL Systems Quantum II (RJL Systems, Clinton
Twp, MI, USA) with the emission of a low electrical current
(500 to 800mA and 50 kHz), and standard protocol was
used.10 The patient was studied after 10 min rest in
the supine position, without shoes and stockings. The
patient’s upper and lower limbs were arranged at an angle
of approximately 30º from the midline. Electrodes were
connected to the hands (wrist and middle ﬁnger) and
feet (ankle and above the knuckle of the toe), after the
areas were cleaned with alcohol. The patient’s right side
was standardised for the test. The instructions for use of
the equipment were obtained from the manufacturer. We
evaluated body fat, lean body mass, and total body water.
Dyspnoea evaluation
Modiﬁed Medical Research Council (MMRC) Dyspnoea Scale
was used to evaluate patient’s dyspnoea perception. MMRC
is a simple self-administered 5-point scale that quantiﬁes
the effect of breathlessness on daily activities.17
Statistical analysis
The primary outcome is rehospitalisation during 6 month
follow-up, and was assessed at follow-up visit, during phone
contact or from medical records. Secondary outcomes were
MNA score and body composition parameters.
Continuous variables are presented as mean values
± standard deviation. Categorical variables are presented as
absolute numbers (%). Differences between the patient sub-
groups (e.g. per MNA risk assessment) were evaluated using
the Student’s t-test, chi-squared test, Mann–Whitney U test,
and analysis of variance (ANOVA) as appropriate. Kaplan–
Meier survival curves were used to present occurrence of
primary endpoints during follow-up. The difference between
patient groups according to the MNA risk assessment was
compared using the log-rank test. The relationship between
primary endpoint and potential predictors was evaluated
with Cox models of proportional hazards. Age, gender,
GOLD stage, body fat mass, lean body mass, and MNA
risk assessment were forced into univariate and adjusted
multivariate model. We report hazard ratios (HR) and
corresponding 95% conﬁdence intervals (CI). SPSS 16.0
software (SPSS Inc., 2007, Chicago, IL, USA) and Prism 5
for Windows (GraphPad Software, Inc., San Diego, CA) was
used for data presentation and statistical calculations. For




Our sample included 22 healthy controls (71±5 years, 59%
men) and 108 COPD patients (71±10 years, 75% men) –
Table 1. Most patients had severe (42%) or very severe
COPD (43%) and received following inhalation therapy: short
acting beta agonists in 95%, long acting beta agonists in 82%,
inhaled corticosteroids in 72%, and tiotropium in 51%.











N 22 108 34 59 15
Age [years] 71±5 71±10 0.95 68±10 71±10 75±7 0.08
Men 13 (59%) 81 (75%) 0.13 28 (82%) 42 (71%) 11 (73%) 0.48
Current or ex-smoker 0 99 (92%) NA 33 (97%) 52 (88%) 14 (93%) 0.19
Pack-years 0 50±32 NA 48±28 49±36 59±22 0.50
MMRC Dyspnoea Scale 1.4±0.6 3.4±1.1 <0.001 3.1±0.9 3.3±1.2 4.0±0.9 0.037
GOLD stage 0 3.3±0.7 NA 3.1±0.7 3.3±0.7 3.6±0.6 0.06
Forced expiratory volume in 1st second [%] 2787±866 943±461 <0.001 1153±544 901±393 625±244 <0.001
Vital capacity [ml] 3627±1174 2251±861 <0.001 2455±952 2231±826 1865±661 0.08
Tiffeneau index [%] 77±5 43±14 <0.001 48±15 34±14 23±9 0.005
Malignancy 0 13 (12%) NA 5 (15%) 6 (10%) 2 (13%) 0.87
Heart failure 0 25 (23%) NA 11 (32%) 10 (17%) 4 (27%) 0.22
Diabetes mellitus 0 17 (16%) NA 11 (32%) 6 (10%) 0 (0%) 0.004
Systolic blood pressure [mmHg] 135±18 137±22 0.70 144±22 134±22 130±21 0.06
Diastolic blood pressure [mmHg] 78±11 79±13 0.66 84±11 78±14 75±13 0.07
Heart rate [beats per minute] 71±13 91±19 <0.001 91±22 91±19 90±15 0.98
Data are presented as mean±standard deviation or number (%).
MMRC: Modiﬁed Medical Research Council; GOLD: Global Initiative for Chronic Obstructive Lung Disease.
Nutritional risk assessment and body composition
MNA score was signiﬁcantly higer in control subjects than
in COPD patients (27.0±1.7 vs 21.2±4.9, p < 0.001). All
control subjects were well nourished and none was at risk
of malnutrition or malnourished. MNA score decreased over
GOLD stage (p = 0.02) and indicated malnutrition in 14% of
patients (6%, 9%, and 21% in GOLD stage 2, 3, and 4 –
p = 0.17), and further 55% were at risk of malnutrition – Fig. 1
and Table 1. Perception of dyspnoea was more severe in
malnourished patients.
Body mass index but not body composition parameters was
higher in control subjects when compared to COPD patients
(29.1±3.8 vs 27.0±6.3, p = 0.041). Table 2 summarizes body
composition parameters in patients divided by MNA risk




























Fig. 1. Nutritional status distribution. Data are presented as points
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Fig. 2. Nutritional status and body fat mass or lean body mass.
Data are presented as points for individual subjects and correlation
lines.
assessment. Malnourished patients were leaner, had lower
body mass, body fat mass, and lean body mass but higher
body fat content when compared with well nourished
patients or patients at risk for malnutrition. A positive
correlation between MNA score, body fat mass (p = 0.001),
and lean body mass (p < 0.001) was observed (Fig. 2).
Prognosis
During 180 days of follow-up, primary endpoint was met
by 45 (41%) patients: 35% of well nourished patients,
39% of patients at risk for malnutrition, and 67% of
malnourished patients (p = 0.10). Nutritional status but not
body composition and GOLD stage were associated with
worse outcome (Fig. 3 and Table 3). Malnourished patients
had higher risk of rehospitalisation in univariate analysis
(HR 2.62, 95%CI 1.13–6.07), which was maintained in an
adjusted model (HR 2.93, 95%CI 1.05–7.32).
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Table 2
Body composition and Mini Nutritional Assessment risk







N 108 34 59 15
Body weight [kg] 76.4±19.5 86.5±15.5 75.9±19.6 56.7±10.6 <0.001
Body height [cm] 168±8 172±6 165±7 167±11 0.001
Body mass index [kg/m2] 27.0±6.3 29.1±4.5 27.6±6.7 20.1±2.8 <0.001
Body fat content [%] 33.7±8.4 32.0±6.6 33.6±8.4 37.7±11.1 0.09
Body fat mass [kg] 25.1±8.2 27.7±7.7 24.9±8.8 20.3±2.6 0.11
Lean body mass [%] 50.0±13.0 58.5±11.2 48.6±10.6 35.9±11.6 <0.001
Lean body mass [kg] 40.2±18.9 51.8±18.5 38.3±16.4 21.4±10.2 <0.001
Total body water [%] 54.0±6.9 52.6±18.5 53.9±7.5 58.0±5.0 0.037
Total body water [kg] 40.0±8.3 45.1±8.1 39.1±7.1 32.4±5.8 <0.001
Data are presented as mean±standard deviation.
Table 3
Cox models for proportional hazards of hospitalisation
Unadjusted model Adjusted model
Age [per 1 year increase] 1.00 [0.97–1.03] 1.00 [0.97–1.04]
Female [vs male] 1.66 [0.88–3.12] 1.68 [0.64–4.42]
GOLD stage [per 1 stage increase] 1.11 [0.72–1.72] 1.04 [0.65–1.66]
Body mass index [per 1 kg/m2 increase] 0.99 [0.94–1.04] 1.02 [0.92–1.14]
Body fat mass [per 1 kg increase] 1.00 [0.96–1.04] 1.00 [0.95–1.04]
Lean body mass [per 1 kg increase] 0.99 [0.97–1.01] 1.00 [0.95–1.04]
Mini Nutritional Assessment
Well nourished Reference Reference
At risk of malnutrition 1.14 [0.57–2.29] 1.02 [0.45–2.32]
Malnourished 2.62 [1.13–6.07] 2.93 [1.05–7.32]
Data are presented as hazard ratios and 95% conﬁdence intervals.
GOLD: Global Initiative for Chronic Obstructive Lung Disease.




























Fig. 3. Kaplan–Meier curves for hospitalisations within 6 months.
Discussion
This prospective study is ﬁrst to report about nutritional
risk assessment, body composition parameters, and hos-
pitalisations in COPD patients. Malnutrition was frequent,
associated with lower body fat mass and lean body mass,
and independently predicted hospitalisations at 6 months.
Patients with chronic diseases, including COPD, are prone
to body wasting, poor nutritional status, and cachexia.3
Little, however, is known about nutritional risk assessment
using the MNA questionnaire. In a study of 32 COPD patients
(71.8±6.0 years, 31 men, FEV1 47±13% predicted), 14
were characterised as at risk of malnutrition, which was
independent of age and body mass index.12 The severity
of dyspnoea as assessed by MMRC Dyspnoea Scale was
signiﬁcantly higher in patients at risk of malnutrition when
compared to well nourished patients (3.1±0.7 vs 2.3±1.0,
p = 0.02). We share this ﬁnding as highest MMRC Dyspnoea
Scale scores were observed in malnourished patients
(p = 0.037, Table 1). Another study investigated determinates
of malnutrition, which was detected in 24 (48%) of
patients.13 Malnourished patients had lower body mass index
(p = 0.001), mid-arm (p = 0.001), and calf circumference
(p = 0.001). They were likely to have lower socioeconomic
status and support, reﬂected through dependence on daily
community service (p = 0.010), living alone (p = 0.048), and
not in their own property (p = 0.024). Finally, the largest
study (N = 460, 75±5 years, 82% men) investigated the
relations between age, COPD and nutritional status.14
S42 B. Benedik et al.
They concluded that severe COPD and advanced age are
independent and likely concurrent conditions that can
cause malnutrition. Additionally, they suggest that MNA
questionnaire gives a valuable insight into nutritional status
with important therapeutic implications.
We conﬁrm many previous ﬁndings and provide additional
insight into nutritional status assessment. We compared
body composition in different nutritional states and
demonstrated that malnourished patients have signiﬁcantly
higher body fat content but signiﬁcantly lower body fat
mass. This ﬁnding could be regarded as contradictory but
it may well have a reasonable explanation. Over COPD
continuum, initially reversible body mass loss is ensuing. As
energy stores per weight unit in fat tissue are about twofold
larger as in muscle tissue, and since physical activity, the
main anabolic trigger is diminishing, skeletal muscle is
depleting faster than fat tissue. This translates to different
proportions between body compartments favouring higher
body fat content. Such observations are shared with other
chronic diseases characterised with body wasting and
cachexia.18,19
From a global perspective, malnutrition is frequent ﬁnding
in European hospitals and is associated with poor outcome.20
In this context, most important ﬁnding of this study is
that malnutrition independently predicted hospitalisations
6 months after discharge. Body mass index, although known
to be associated with mortality,5 and body composition
parameters were not predictive of outcome. This, in
turn, means that MNA questionnaire carries more messages
for the clinicians who would like to prevent recurrent
hospitalisations in COPD patients. Additionally, results of
MNA questionnaire are easier to translate to clinical
practice than results of body composition assessment.
An important aspect is that malnutrition, as opposed
to cachexia, is accessible to effective management.21
Nutritional interventions, combined with anabolic stimuli,
can reverse nutritional status and reduce mortality risk.22
Limitations
This study needs to be interpreted with some caution.
Sample size may be regarded as insufﬁcient and mortality
could be more objective outcome measure. Nonetheless,
considering high event rate of 41% during 6 months of
follow-up and signiﬁcant hospitalisation burden, both for
patient and health care system, renders hospitalisations as
attractive target to focus on. This is particularly true in
light of relatively optimal pharmacological therapy23 which
however has no proven mortality beneﬁt.16
Conclusions and clinical implications
Our and previous ﬁndings suggest that nutritional risk
assessment should be part of routine practice in COPD
management. It can guide self-care behaviour counselling,
therapeutic education, speciﬁc nutritional interventions,24
training modalities,25 and pharmacological interventions.26
Particular attention needs to be given to malnourished
patients who are at high risk of rehospitalisations, inde-
pendent of their body size and composition. Future studies
have to investigate whether malnutrition is associated with
mortality and whether this effect is independent of other
known outcome predictors.
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